Innovative ETFs Content Hub Healthcare, Biotech ETFs Plunge on Mounting Political Pressures By Max ChenApril 18, 2019
Innovative ETFs Content Hub Healthcare ETFs Lag the Broader Market Amidst Regulation Scare By Max ChenApril 15, 2019
Equity ETF Content Hub Tom Lydon on CNBC: Can Health Care Cure Itself? By Ben HernandezApril 15, 2019
Relative Value Content Hub Will Tighter Government Regulation Test Health Care ETFs? By Ben HernandezApril 15, 2019
Innovative ETFs Content Hub Healthcare ETFs Deteriorate on Congress’ Threats to Drug Prices By Max ChenApril 12, 2019
Leveraged & Inverse Content Hub Health Care ETFs Get a Boost From Latest Jobs Report By Ben HernandezApril 6, 2019
Innovative ETFs Content Hub Healthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain Outlook By Max ChenMarch 6, 2019
Core Equity Content Hub Healthcare ETFs Slip After Abbot Lab’s Revenue Miss, Weak Outlook By Max ChenJanuary 23, 2019
Equity ETFs Healthcare ETFs Looked Pale on Reports J&J Knew About Asbestos in Baby Powder By Max ChenDecember 14, 2018
